Rasdegafusp alfa Uses, Dosage, Side Effects and more
Rasdegafusp alfa is under investigation in clinical trial NCT03206047 (Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer).
| Trade Name | Rasdegafusp alfa |
| Generic | Rasdegafusp alfa |
| Rasdegafusp alfa Other Names | Rasdegafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
